MedTrace Logo

Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients

NCT01021046 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78

Last updated 2010-08-03

No results posted yet for this study

Summary

The purpose of this study is to study whether deep anterior lamellar keratoplasty (DALK) using acellular tissue will promote corneal graft survival in high risk patients.

Conditions

  • Glycerin Cryopreserved Acellular Corneal Tissue
  • Deep Anterior Lamellar Keratoplasty
  • High Risk Keratoplasty

Interventions

PROCEDURE

DALK using GCCT

Deep anterior lamellar keratoplasty (DALK) using glycerin-cryopreserved corneal tissue

PROCEDURE

DALK using FCT

Deep anterior lamellar keratoplasty (DALK) using fresh corneal tissue

Sponsors & Collaborators

  • Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Wei Chen, MD,PhD · Eye Hospital, Wenzhou Medical College, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2010-07-31
Completion
2010-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01021046 on ClinicalTrials.gov